Education
About Us
Working with TipRanks
Follow Us
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged (TSE:ABT)
TSX:ABT
| Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|
| Income Statement | |||
| Total Revenue | $ 104.67M | $ 98.91M | $ 93.62M |
| Gross Profit | $ 92.04M | $ 85.93M | $ 79.26M |
| Operating Income | $ 15.27M | $ 10.90M | $ 2.88M |
| EBITDA | $ 21.18M | $ 14.53M | $ 15.26M |
| Net Income | $ 10.63M | $ 7.58M | $ 3.11M |
| Balance Sheet | |||
| Cash & Short-Term Investments | $ 47.08M | $ 35.80M | $ 34.33M |
| Total Assets | $ 130.19M | $ 103.31M | $ 97.03M |
| Total Debt | $ 10.14M | $ 0.00 | $ 0.00 |
| Net Debt | $ -19.59M | $ -18.69M | $ -33.96M |
| Total Liabilities | $ 173.25M | $ 153.93M | $ 153.54M |
| Stockholders' Equity | $ -43.06M | $ -50.62M | $ -56.51M |
| Cash Flow | |||
| Free Cash Flow | $ 21.10M | $ 7.18M | $ 9.64M |
| Operating Cash Flow | $ 24.96M | $ 10.26M | $ 12.55M |
| Investing Cash Flow | $ -3.82M | $ -19.78M | $ -2.91M |
| Financing Cash Flow | $ -9.73M | $ -5.68M | $ -8.16M |